Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04302259 · ClinicalTrials.gov registry record · NA

Intelligent Spine Interface, Clinical (ISI-C)

A NA study of Spinal Cord Injury, sponsored by Rhode Island Hospital.

Active
Registry status
NA
Development phase
3
Enrollment target
1
Study location

NCT04302259: Active NA study of Spinal Cord Injury, sponsored by Rhode Island Hospital.

NCT04302259 is a NA study of Spinal Cord Injury that is active but no longer recruiting, run by Rhode Island Hospital. The registered enrollment target is 3 participants, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04302259, a NA study of Spinal Cord Injury, is active but no longer recruiting, sponsored by Rhode Island Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
3 participants
Enrollment target
1
Study location

Study Summary

This research study is being done to test a new device developed for spinal cord injury (SCI) patients. The purpose of this study is to collect data on how the nervous system signals travel within the spinal cord of SCI patients. Once the investigators understand that, they hope to develop a device that may help rehabilitation of SCI patients so that they can regain function in their lower limbs. This study involves some imaging studies (e.g. X-rays etc.), surgical implantation of a portion of the electrical stimulation device, various assessments of body function (e.g. balance, movement, gait), and physical rehabilitation procedures. What is new and experimental is the stimulation/sensing device (Intelligent Spine Interface - Commercial, ISI-C) that will be implanted.

Primary Outcome

Evaluate safety issues associated with the implantation and use of ISI technology i.e. frequency of device related adverse events

Conditions Studied

Spinal Cord Injury

Interventions

  • DEVICE Intelligent Spine Interface

Study Locations (1)

Rhode Island

  • Rhode Island Hospital - Providence

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2021-09-01
Est. Completion 2025-06-30
Phase NA
Rhode Island Hospital

130 total trials

What the registry record for NCT04302259 still lists

NCT04302259 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Spinal Cord Injury appearing as the primary indexed condition, and to 1 intervention - of which Intelligent Spine Interface is the first listed.

NCT04302259 reports a single indexed study location in Rhode Island.

Frequently Asked Questions

What is clinical trial NCT04302259 about?

NCT04302259 is a clinical study titled "Intelligent Spine Interface, Clinical (ISI-C)". This research study is being done to test a new device developed for spinal cord injury (SCI) patients. The purpose of this study is to collect data on how the nervous system signals travel within the spinal cord of SCI patients. Once the investigators understand that, they hope to develop a device ...

What is the current status of trial NCT04302259?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 3 participants. The study started on 2021-09-01. Estimated completion is 2025-06-30.

What conditions does trial NCT04302259 study?

This clinical trial studies the following conditions: Spinal Cord Injury.

What interventions are being tested in trial NCT04302259?

The interventions under investigation include: Intelligent Spine Interface (DEVICE).

Who is sponsoring clinical trial NCT04302259?

This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04302259 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Spinal Cord Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04302259's enrollment target sits among peer trials

3 99th of 99 higher than 1 of 99 other Spinal Cord Injury trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Spinal Cord Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT04302259, the US trial registry maintained by the National Library of Medicine. NCT04302259 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.